DACS
IMVT icon

Dymon Asia Capital (Singapore)’s Immunovant IMVT Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
49,805
+26,000
+109% +$792K 0.08% 128
2026
Q1 		$591K Sell
23,805
-5,400
-18% -$140K 0.06% 207
2025
Q4 		$742K Buy
29,205
+11,300
+63% +$252K 0.07% 186
2025
Q3 		$289K Buy
+17,905
New +$290K 0.03% 237

Other funds holding IMVT

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $213M AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s IMVT Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) increased its Immunovant (IMVT) stake by 109% in Q2 2026, buying an estimated $792K and bringing the position to 49,805 shares worth $1.92M. The position accounts for 0.08% of the portfolio, ranked #128.

Dymon Asia Capital (Singapore) first reported a position in IMVT in Q3 2025 and has held it in 4 quarters since. 37 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 49,805 shares of Immunovant worth $1.92M as of Q2 2026.
  • Dymon Asia Capital (Singapore) bought 26,000 Immunovant shares in Q2 2026, an estimated $792K.
  • Immunovant made up 0.08% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #128 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Immunovant in Q3 2025 and has held it in 4 quarters since.
  • 37 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.